The Natural History of Type 2 Diabetes Varies Between Clinical Subphenotypes of At-Risk Individuals

by Prateek Chopra | June 25, 2026 | Diabetes Conferences | ADA 2026

Research Objective

  • This study investigated metabolic trajectories preceding the onset of type 2 diabetes (T2D) among distinct high-risk subphenotypes.
  • The aim was to better understand how differences in insulin sensitivity, beta-cell function, and body fat distribution contribute to diabetes development.

Methods

  • Individuals at elevated risk of T2D from the TUEF/TULIP cohort in Germany who subsequently developed diabetes were included.
  • Participants underwent:
    • Serial 75-g oral glucose tolerance tests (OGTTs).
    • Whole-body MRI for assessment of body fat distribution.
    • Proton magnetic resonance spectroscopy for liver fat quantification.
  • Insulin sensitivity and beta-cell function indices were derived from OGTT data.

High-Risk Metabolic Clusters

  • Cluster C3: Reduced beta-cell function.
  • Cluster C5: High visceral fat, high liver fat, and marked insulin resistance.
  • Cluster C6: High visceral fat and elevated insulin secretion.

Study Population

  • C3: 162 participants.
  • C5: 148 participants.
  • C6: 48 participants.
  • Mean observation period before T2D diagnosis: 3.5 ± 3.7 years.

Changes in Insulin Sensitivity

  • Insulin sensitivity declined significantly in:
    • C3 (p<0.046).
    • C6 (p<0.018).
  • No significant decline was observed in C5 (p=0.299).

Changes in Beta-Cell Function

  • The greatest deterioration was observed in C5 (p<0.001).
  • A modest decline occurred in C3 (p=0.004).
  • Beta-cell function remained stable in C6 (p=0.501).

Adiposity Trajectories

  • Neither visceral fat nor liver fat changed significantly within individual clusters over time.
  • However, visceral fat accumulated more rapidly in C5 than in C3:
    • Slope: 0.058 vs 0.039 (p=0.031).

Clinical Implications

  • The biological pathways leading to T2D differ substantially among high-risk individuals.
  • Some subgroups are characterized primarily by declining insulin sensitivity, whereas others exhibit accelerated beta-cell dysfunction.
  • Recognition of these distinct trajectories may support more personalized diabetes prevention strategies.

High-risk metabolic subphenotypes follow different pathways toward the development of T2D. While progressive insulin resistance predominates in some individuals, accelerated beta-cell deterioration drives diabetes onset in others, highlighting the need for tailored prevention approaches based on underlying metabolic characteristics.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top